News

Fannie Mae's Groundbreaking Credit Risk Transfer Deal of 2024

Fannie Mae's Groundbreaking Credit Risk Transfer Deal of 2024

New Enhancements Introduced to the CIRT Structure

Fannie Mae has recently completed another significant Credit Insurance Risk Transfer™ (CIRT™) transaction, marking its seventh deal of 2024. This important transaction saw the transfer of an impressive $338.6 million in mortgage credit risk to various private insurers and reinsurers, aligning with the organization's commitment to innovative risk management.

The Impact of CIRT 2024-L4

The covered loan pool in this transaction comprises around 23,500 single-family mortgage loans, totaling approximately $7.9 billion in unpaid principal balance (UPB). These loans were acquired under rigorous standards, reinforcing Fannie Mae's dedication to maintaining a high quality of mortgages. The loans featured a loan-to-value (LTV) ratio ranging from 60.01 to 80.00 percent, showcasing the conservative underwriting practices employed.

Risk Retention and Mitigation

As part of the CIRT 2024-L4 program, Fannie Mae is retaining the risk for the first 170 basis points of loss on the entire $7.9 billion loan pool. If the initial retention layer of $133.9 million is exhausted, the 26 participating insurers and reinsurers will then cover the subsequent loss up to an additional 430 basis points, providing a substantial safety net for Fannie Mae's operations.

Innovative Insurance Policies

A noteworthy feature of the updated CIRT insurance policy allows for a quicker release of coverage over the lifetime of the transaction, contingent on the continued good performance of the loan pool. Rather than being tied to the total outstanding balance, the insurance premium will now depend solely on the amount of coverage remaining. This flexibility is expected to encourage more insurers to participate in such transactions.

Long-Term Coverage Commitment

The coverage drawn from this deal will persist based on real losses sustained over an 18-year term. The potential to decrease coverage amounts each month after the policy’s effective date adds an additional layer of strategic oversight for Fannie Mae, reflecting its adaptive approach to market changes.

A Look at Past Acquisitions

Since initiating its CIRT program, Fannie Mae has amassed approximately $28.1 billion in insurance coverage on $935 billion worth of single-family loans. This robust program allows the company to navigate risk more effectively while providing essential services and support in the mortgage marketplace. The willingness to share credit risk through innovative mechanisms has positioned Fannie Mae as a leader in mortgage finance.

Transparency and Data-Sharing Initiatives

Fannie Mae is committed to promoting transparency regarding its credit risk transfer processes. To facilitate insurers and reinsurers in assessing potential risks, the company offers comprehensive ongoing disclosure data. Access to detailed analytics and resources is available to all market participants interested in engaging with the CIRT program.

About Fannie Mae

Fannie Mae is dedicated to promoting equitable and sustainable access to homeownership and affordable rental housing across the nation. The organization's innovative practices, such as supporting the 30-year fixed-rate mortgage, demonstrate its commitment to making homebuying easier and more accessible for individuals and families. For further insights and information about Fannie Mae, visit their official website or engage with their various social media channels.

Frequently Asked Questions

What is the purpose of Fannie Mae’s CIRT program?

The CIRT program facilitates the transfer of credit risk to private insurers and reinsurers, enhancing Fannie Mae's ability to manage mortgage credit risk.

How much risk is retained by Fannie Mae in the latest transaction?

In the CIRT 2024-L4 transaction, Fannie Mae retains the risk for the first 170 basis points of loss on a total coverage of $7.9 billion.

What are the benefits of the updated CIRT insurance policy?

The updated policy allows for quicker coverage releases if the loans perform well and makes premiums based on remaining coverage, increasing efficiency.

How does Fannie Mae ensure the quality of the loans in this program?

The loans included typically adhere to rigorous credit standards and are underwritten with enhanced risk controls for better stability.

What is the total insurance coverage acquired by Fannie Mae through CIRT?

To date, Fannie Mae has secured about $28.1 billion in insurance coverage on $935 billion worth of single-family loans through the CIRT program.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Findings on gMG Treatments by UCB at AANEM 2024

Updated Category News Views 127

UCB Highlights Innovations in Generalized Myasthenia Gravis Treatments at AANEM 2024 UCB, a prominent global biopharmaceutical company, is gearing up to present its latest findings in the management of generalized myasthenia gravis (gMG) at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting. The event, which will also feature...

Continue Reading
Lysander Funds Shares New Distributions Estimates for ETFs

Updated Category News Views 131

Lysander Funds Shares New Distributions Estimates Lysander Funds Limited recently made an announcement about the anticipated cash distributions for December 2024 for their exchange-traded funds (ETFs). The focus is on three notable ETFs: Lysander-Slater Preferred Share ActivETF, Lysander-Canso Corporate Treasury ActivETF, and Lysander-Canso Floating Rate ActivETF. Each of...

Continue Reading
Empowering Girls: Pace Center's Initiatives for Growth

Updated Category News Views 350

Introduction to the Capital Campaign Pace Center for Girls Hillsborough is excited to announce its capital campaign aimed at expanding its capacity and enhancing the support provided to girls in the community. Through dedicated efforts such as education, counseling, and training, this campaign signifies a crucial step towards bettering the future for girls in Hillsborough...

Continue Reading
Bank of America Sees Growth in Loans, Deposits Amid Profit Rise

Updated Category News Views 284

Bank of America Reports Increased Earnings and Efficiency Bank of America Corp (NASDAQ: BAC) has announced strong financial results for the second quarter, showcasing impressive growth in loans, deposits, and overall profitability. The bank reported a net income of $7.1 billion, a slight increase from $6.9 billion the previous year, along with an earnings per share (EPS)...

Continue Reading
Investigating Manitex International: A Closer Look at MNTX

Updated Category News Views 72

Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...

Continue Reading